|
Indonesia: PharmaceuticalPublished by: Internet Securities, Inc. (Intellinews) Published: Jan. 29, 2008 - 19 Pages Table of Contents
AbstractThe Indonesian pharmaceutical sector experienced a growth in value, from USD1.6 billion at the end of 2006 to USD1.7 billion as at August 2007. Domestic manufacturing continues to develop and the possibilities of mergers between leading state-owned companies should boost the industry further. In 2006, Indonesian pharmaceutical companies controlled 65% of prescription sales and 75% of over-the-counter medicines relative to their foreign counterparts. Also, due to the decrease in generic drugs prices in 2006, it is anticipated that the generic drugs market will grow at an accelerated pace.Although Indonesia’s knowledge of pharmaceutical medicine is still in an early phase, there is plenty of room for the industry to grow. It is expected that the market will grow at an average annual rate of 6.62% over the next 6 years. The Indonesian Investment Coordinating Board announced that in the first half of 2006, 24 separate foreign investors registered investment plants to construct new pharmaceutical factories. Indonesia’s pharmaceutical market has potential to expand with a large domestic market and ASEAN commitments which will open their markets to prescription drugs and ASEAN produced pharmaceutical products by 2008. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||